{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:31:17Z","timestamp":1791844277744,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010133","name":"Aarne Koskelon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ijcard.2020.08.069","type":"journal-article","created":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T19:26:17Z","timestamp":1598124377000},"page":"191-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock \u2013 Insights from the CardShock study"],"prefix":"10.1016","volume":"322","author":[{"given":"Anu","family":"Kataja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuukka","family":"Tarvasm\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Lassus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sionis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Pulkki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Banaszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Carubelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Hongisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raija","family":"Jurkko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"J\u00e4ntti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kasztura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Parissis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuija","family":"Sabell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Silva-Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindrich","family":"Spinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Tolppanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli-Pekka","family":"Harjola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.ijcard.2020.08.069_bb0005","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/archinte.165.14.1643","article-title":"Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock","volume":"165","author":"Kohsaka","year":"2005","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.ijcard.2020.08.069_bb0010","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/CIRCULATIONAHA.106.613596","article-title":"Cardiogenic shock: current concepts and improving outcomes","volume":"117","author":"Reynolds","year":"2008","journal-title":"Circulation."},{"issue":"16","key":"10.1016\/j.ijcard.2020.08.069_bb0015","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary Management of Cardiogenic Shock: a scientific statement from the American Heart Association","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2020.08.069_bb0020","article-title":"Molecular signature of cardiogenic shock","author":"Iborra-Egea","year":"2019","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2020.08.069_bb0025","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00392-007-0626-5","article-title":"Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock","volume":"97","author":"Debrunner","year":"2008","journal-title":"Clin. Res. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2020.08.069_bb0030","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/01.CCM.0000228919.33620.D9","article-title":"Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction","volume":"34","author":"Geppert","year":"2006","journal-title":"Crit. Care Med."},{"issue":"5","key":"10.1016\/j.ijcard.2020.08.069_bb0035","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00392-011-0403-3","article-title":"Interleukin-6, \u22127, \u22128 and \u221210 predict outcome in acute myocardial infarction complicated by cardiogenic shock","volume":"101","author":"Prondzinsky","year":"2012","journal-title":"Clin. Res. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2020.08.069_bb0040","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1097\/00003246-200209000-00007","article-title":"Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6","volume":"30","author":"Geppert","year":"2002","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.ijcard.2020.08.069_bb0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/SHK.0000000000000756","article-title":"Infectious complications and immune\/inflammatory response in cardiogenic shock patients: a prospective observational study","volume":"47","author":"Parenica","year":"2017","journal-title":"Shock"},{"issue":"21","key":"10.1016\/j.ijcard.2020.08.069_bb0050","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ijcard.2020.08.069_bb0055","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.CCM.0000194725.48928.3A","article-title":"Sepsis in European intensive care units: results of the SOAP study","volume":"34","author":"Vincent","year":"2006","journal-title":"Crit. Care Med."},{"issue":"6","key":"10.1016\/j.ijcard.2020.08.069_bb0060","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjcard.2006.10.040","article-title":"Microbiological profile of septic complication in patients with cardiogenic shock following acute myocardial infarction (from the SHOCK study)","volume":"99","author":"Kohsaka","year":"2007","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2020.08.069_bb0065","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00003246-200004000-00011","article-title":"Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit","volume":"28","author":"Muller","year":"2000","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.ijcard.2020.08.069_bb0070","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3343\/alm.2014.34.4.263","article-title":"Update on procalcitonin measurements","volume":"34","author":"Meisner","year":"2014","journal-title":"Ann Lab Med."},{"issue":"2","key":"10.1016\/j.ijcard.2020.08.069_bb0075","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1086\/421997","article-title":"Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis","volume":"39","author":"Simon","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijcard.2020.08.069_bb0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1741-7015-9-107","article-title":"Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future","volume":"9","author":"Schuetz","year":"2011","journal-title":"BMC Med."},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2020.08.069_bb0085","first-page":"S57","article-title":"Physiology and genetics of procalcitonin","volume":"49","author":"Maruna","year":"2000","journal-title":"Physiol. Res."},{"issue":"4","key":"10.1016\/j.ijcard.2020.08.069_bb0090","doi-asserted-by":"crossref","first-page":"R152","DOI":"10.1186\/cc11467","article-title":"Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction","volume":"16","author":"Andrie","year":"2012","journal-title":"Crit. Care"},{"issue":"9","key":"10.1016\/j.ijcard.2020.08.069_bb0095","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2020.08.069_bb0100","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2215\/CJN.06870909","article-title":"Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size","volume":"5","author":"Michels","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.ijcard.2020.08.069_bb0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11739-010-0462-x","article-title":"Procalcitonin in acute cardiac patients","volume":"6","author":"Picariello","year":"2011","journal-title":"Intern. Emerg. Med."},{"issue":"9713","key":"10.1016\/j.ijcard.2020.08.069_bb0110","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","article-title":"Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial","volume":"375","author":"Bouadma","year":"2010","journal-title":"Lancet."},{"issue":"7","key":"10.1016\/j.ijcard.2020.08.069_bb0115","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","article-title":"Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial","volume":"16","author":"De Jong","year":"2016","journal-title":"Lancet Infect Dis."},{"issue":"4","key":"10.1016\/j.ijcard.2020.08.069_bb0120","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/00313020701444564","article-title":"Procalcitonin for the clinical laboratory: a review","volume":"39","author":"Schneider","year":"2007","journal-title":"Pathology."},{"issue":"8","key":"10.1016\/j.ijcard.2020.08.069_bb0125","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1007\/s00134-003-1827-7","article-title":"Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock","volume":"29","author":"Geppert","year":"2003","journal-title":"Intensive Care Med."},{"issue":"5","key":"10.1016\/j.ijcard.2020.08.069_bb0130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11739-009-0277-9","article-title":"Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention","volume":"4","author":"Picariello","year":"2009","journal-title":"Intern. Emerg. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2020.08.069_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0167-5273(99)00118-7","article-title":"Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation","volume":"72","author":"Brunkhorst","year":"1999","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2020.08.069_bb0140","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00003246-199704000-00009","article-title":"Cytokines, nitrite\/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia","volume":"25","author":"de Werra","year":"1997","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ijcard.2020.08.069_bb0145","article-title":"Septic participation in cardiogenic shock: exposure to bacterial endotoxin","volume":"15","author":"Ramirez","year":"2016","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.ijcard.2020.08.069_bb0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/SHK.0000000000000497","article-title":"Recent advances in biomarkers in severe burns","volume":"45","author":"Ruiz-Castilla","year":"2016","journal-title":"Shock."},{"key":"10.1016\/j.ijcard.2020.08.069_bb0155","article-title":"Levels of growth differentiation factor 15 and early mortality risk stratification in cardiogenic shock","volume":"13","author":"Hongisto","year":"2019","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2020.08.069_bb0160","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.healun.2018.07.009","article-title":"Advancing from a \u201chemodynamic model\u201d to a \u201cmechanistic disease-modifying model\u201d of cardiogenic shock","volume":"37","author":"Lawler","year":"2018","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.ijcard.2020.08.069_bb0165","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ijcard.2020.08.069_bb0170","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S2213-2600(18)30287-X","article-title":"Heterogeneity and phenotypic stratification in acute respiratory distress syndrome","volume":"6","author":"Lawler","year":"2018","journal-title":"Lancet Respir. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320336524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320336524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:50:06Z","timestamp":1759092606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527320336524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":34,"alternative-id":["S0167527320336524"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.08.069","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock \u2013 Insights from the CardShock study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.08.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}